Home › Funds › CAPITAL MANAGEMENT CORP /VA › HRMY

CAPITAL MANAGEMENT CORP /VA position in HRMY

HARMONY BIOSCIENCES HLDGS IN · Health Care

CAPITAL MANAGEMENT CORP /VA reported holding 281,865 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q3 2026 13F filing — a position valued at US$11.1M, representing 1.66% of its reported portfolio and ranking #29 among its reported holdings. CAPITAL MANAGEMENT CORP /VA has disclosed HRMY holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)281.87K sh
Reported value held$11.07M
Portfolio Weight1.66%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL MANAGEMENT CORP /VA's HRMY position evolved

CAPITAL MANAGEMENT CORP /VA first disclosed a stake in HRMY in Q1 2024 at 208,994 shares (US$7.0M). The position peaked in Q4 2024 at 340,960 shares, worth US$11.7M. Across 11 filings, CAPITAL MANAGEMENT CORP /VA increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 281,865 shares valued at US$11.1M — a reduction of -3,635 shares quarter over quarter.. Notable position changes include a 43% increase in Q4 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 208.99K $7.02M New
Q2 2024 240.04K $7.24M Add
Q3 2024 237.65K $9.51M Reduce
Q4 2024 340.96K $11.73M Add
Q1 2025 341.96K $11.35M Hold
Q2 2025 352.57K $11.14M Add
Q3 2025 322.91K $8.90M Reduce
Q4 2025 281.72K $10.54M Reduce
Q1 2026 317.93K $8.91M Add
Q2 2026 285.50K $10.40M Reduce
Q3 2026 281.87K $11.07M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRMY and 13F data

HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 38 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRMY

All HRMY fund holders →

FAQ

How long has CAPITAL MANAGEMENT CORP /VA held HRMY?

CAPITAL MANAGEMENT CORP /VA has disclosed HRMY holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is CAPITAL MANAGEMENT CORP /VA's current position in HRMY?

As of Q3 2026, CAPITAL MANAGEMENT CORP /VA holds 281.87K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $11.07M, representing 1.66% of its reported portfolio and ranking #29.

Has CAPITAL MANAGEMENT CORP /VA been buying or selling HRMY?

In the latest 13F filing (Q3 2026), CAPITAL MANAGEMENT CORP /VA reduced its position in HRMY. The position peaked in Q4 2024 at 340.96K shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.